ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL239129
CHEMBL239129
Compound Name MEGLUMINE ANTIMONATE
ChEMBL Synonyms MEGLUMINE ANTIMONATE
Max Phase 3
Trade Names
Molecular Formula C7H18NO8Sb

Sources

  • Scientific Literature
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL239129 compound icon
Drug Type:Synthetic Small Molecule Rule of Five:N First In Class:N Chirality:Unknown Prodrug:N Oral:Unclassified Parenteral:Unclassified Topical:Unclassified Black Box:Unclassified Availability Type:Unclassified

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Leishmaniasis, MucocutaneousD007897EFO:0007379mucocutaneous Leishmaniasis2ClinicalTrials
LeishmaniasisD007896EFO:0005044Leishmaniasis2ClinicalTrials
Leishmaniasis, CutaneousD016773EFO:0005046cutaneous Leishmaniasis3ClinicalTrials

Clinical Data

ClinicalTrials.gov MEGLUMINE ANTIMONATE
The Cochrane Collaboration MEGLUMINE ANTIMONATE

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Compound Cross References

ATC P - ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 - ANTIPROTOZOALS
P01C - AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
P01CB - Antimony compounds
P01CB01 - meglumine antimonate

ChemSpider ChemSpider Identifier not yet assigned
Wikipedia Meglumine_antimoniate
spacer
spacer